Servizo Galego de Saúde FONDO EUROPEO DE DESENVOLVEMENTO REXIONAL 'Unha maneira de facer Europa' UNIÓN EUROPEA
Bibliografía

Bibliografía

Bibliografia.png 
 
  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10.
  2. Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JA, Gordo F, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med. 2007; 35(5):1284-9.
  3. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013; 369(21):2063.
  4. Suarez D, Ferrer R, Artigas A, Azkarate I, Garnacho-Montero J, Gomà G, et al. Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain. Intensive Care Med. 2011; 37(3):444-52.
  5. Lu Y, Zhang H, Teng F, Xia WJ, Sun GX, Wen AQ. Early Goal-Directed Therapy in Severe Sepsis and Septic Shock: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials. J Intensive Care Med. 2018; 33(5):296-309.
  6. Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014; 42(8):1749-55.
  7. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34(6):1589-96.
  8. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):775-87.
  9. Mackway-Jones K, Marsden J, Windle J. Emergency Triage: Manchester Triage Group, 3th ed. London. BMJ Books; 2014.
  10. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017; 43(3):304-77.
  11. Borges M. “Código sepsis”. Documento de Consenso. Madrid 2014.
  12. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010; 36(2):222-31.
  13. Dellinger RP, Schorr CA, Levy MM. A users’ guide to the 2016 Surviving Sepsis Guidelines. Intensive Care Med. 2017; 43(3):299-303.
  14. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010; 303(8):739-46.
  15. Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010; 182(6):752-61.
  16. Van Engelen TSR, Wiersinga WJ, Scicluna BP, van der Poll T. Biomarkers in Sepsis. Crit Care Clin. 2018; 34(1):139-52.
  17. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009; 136(5): 1237-48.
  18. Lam SW, Bauer SR, Fowler R, Duggal A. Systematic Review and Meta-Analysis of Procalcitonin-Guidance Versus Usual Care for Antimicrobial Management in Critically Ill Patients: Focus on Subgroups Based on Antibiotic Initiation, Cessation, or Mixed Strategies. Crit Care Med. 2018; 46(5):684-90.
  19. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernández-Delgado E, Herrera-Melero I, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014; 40(1):32-40.
  20. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22(7):707-10.
  21. Park HK, Kim WY, Kim MC, Jung W, Ko BS. Quick sequential organ failure assessment compared to systemic inflammatory response syndrome for predicting sepsis in emergency department. J Crit Care. 2017; 42:12-7.
  22. Teboul JL, Saugel B, Cecconi M, De Backer D, Hofer CK, Monnet X, et al. Less invasive hemodynamic monitoring in critically ill patients. Intensive Care Med. 2016; 42(9):1350-9.
  23. Hoste EA, Maitland K, Brudney CS, Mehta R, Vincent JL, Yates D, et al. Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth. 2014; 113(5):740-7.
  24. Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014; 370(17):1583-93.
  25. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003; 31(12):2742-51.
  26. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, et al. A randomized trial of protocolbased care for early septic shock. N Engl J Med. 2014; 370(18):1683-93.
  27. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Trial of early, goaldirected resuscitation for septic shock. N Engl J Med. 2015; 372(14):1301-11.
  28. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014; 371(16):1496-506.
  29. Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R, et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011; 37(1):86-96.
  30. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013; 369(13):1243-51.
  31. Lira A, Pinsky MR. Choices in fluid type and volume during resuscitation: impact on patient outcomes. Ann Intensive Care. 2014; 4:38.
  32. Raghunathan K, Murray PT, Beattie WS, Lobo DN, Myburgh J, Sladen R, et al. Choice of fluid in acute illness: what should be given? An international consensus. Br J Anaesth. 2014; 113(5):772-83.
  33. Raghunathan K, Nailer P, Konoske R. What is the ideal crystalloid? Curr Opin Crit Care. 2015; 21(4): 309-14.
  34. Raghunathan K, Shaw A, Nathanson B, Stürmer T, Brookhart A, Stefan MS, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med. 2014; 42(7):1585-91.
  35. Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014; 370(15):1412-21.
  36. Caironi P, Langer T, Gattinoni L. Albumin in critically ill patients: the ideal colloid? Curr Opin Crit Care. 2015; 21(4):302-8.
  37. Zazzeron L, Gattinoni L, Caironi P. Role of albumin, starches and gelatins versus crystalloids in volume resuscitation of critically ill patients. Curr Opin Crit Care. 2016; 22(5):428-36.
  38. De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med. 2012; 40(3):725-30.
  39. Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Ellingson KD, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014; 35 Suppl 2:S21-31.
  40. O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011; 39(4 Suppl 1):S1-34.
  41. Grupo de traballo EPINE. Estudio de prevalencia de las infecciones nosocomiales en España. Análisis EPINE-EPPS 2017. Informe global de España (resumo)[internet]. Madrid: Sociedad Española de Medicina Preventiva, Salud Pública e Higiene; 2017 [acceso 11 de xaneiro de 2018]. Dispoñible en:
    http://hws.vhebron.net/epine/Global/EPINE-EPPS%202017%20Informe%20Global%20de%20Espa%C3%B1a%20Resumen.pdf
  42. Grupo de traballo da Ponencia de Vigilancia Epidemiológica. Documento marco del sistema nacional de vigilancia de infecciones relacionadas con la asistencia sanitaria [internet]. Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2015 [acceso 11 de xaneiro de 2018]. Dispoñible en:
    http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-procedimientos/pdf_2016/Documento_marco_Vigilancia_IRAS.pdf
  43. Xunta de Galicia. Consellería de Sanidade. Dirección xeral de Saúde Pública. Actualización do calendario de vacinación infantil [internet]. Xaneiro de 2017 [acceso 20 de xaneiro de 2018]. Dispoñible en:
    https://www.sergas.gal/Saude-publica/Documents/4146/Nota_informativa_calendario_galego_firmas.pdf
  44. Xunta de Galicia. Consellería de Sanidade. Dirección xeral de Saúde Pública. Calendario de vacinación de adultos [internet]. Xullo de 2017 [acceso 20 de xaneiro de 2018]. Dispoñible en:
    https://www.sergas.gal/Saude-publica/Documents/4504/NOTA%20INFORMATIVA%20DEF%20CALEND_VACINACION_ADULTOS_GALEGO.pdf
  45. Xunta de Galicia. Consellería de Sanidade. Dirección xeral de Saúde Pública. Vacinación antipneumocócica en adultos [internet]. Xullo de 2017 [acceso 20 de xaneiro de 2018]. Dispoñible en:
    https://www.sergas.gal/Saude-publica/Documents/4536/Nota_informativa_vacinacion_antipneumococica_2017.pdf
  46. Ponencia de Programas y Registro de Vacunaciones. Adenda. Modificación en “Recomendaciones de utilización de la vacuna frente a enfermedad meningocócica por serogrupo B”. Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad, 2015.
  47. Asociación Española de Normalización y Certificación (AENOR). Norma UNE 179006. Sistema de vixilancia, prevención e control das infeccións relacionadas coa atención sanitaria. 2013.
  48. Subdirección Xeral de Atención ao Cidadán e Calidade. Sistema de Seguridade do Paciente e Xestión de Riscos Sanitarios. Do modelo corporativo de xestión integrada da calidade do Servizo Galego de Saúde. Santiago de Compostela: Xunta de Galicia. Servizo Galego de Saúde; 2014.
  49. Ministerio de Sanidad, Servicios Sociales e Igualdad. Seguridad del Paciente. Proyectos Tolerancia Zero en las UCIS [internet]. Dispoñible en:
    https://www.seguridaddelpaciente.es/es/proyectos/financiacion-estudios/proyectos-tolerancia-zero/
  50. Infección quirúrgica Zero [internet]. Madrid: Sociedad Española de Medicina Preventiva, Salud Pública e Higiene; 2016 [acceso 29 de xaneiro de 2018]. Dispoñible en:
    http://infeccionquirurgicazero.es/es/